News

Category:
|
July 7, 2021

Dewpoint scientific founder Tony Hyman elected to the Leopoldina National Academy of Sciences

Dewpoint congratulates our scientific founder, Tony Hyman, for his election to the German Academy of Sciences Leopoldina. This prestigious award recognizes Hyman’s outstanding scientific achievements in the field of Genetics/Molecular Biology and Cell Biology.

Read more on leopoldina.org

Media Contact

Jeanette Bressi
VP, Head of Communications & PR
Dewpoint Therapeutics
+1 609-439-3997 | jbressi@dewpointx.com

Investor Contact

Scott Peterson, Ph.D.
SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
speterson@dewpointx.com
Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science